Breaking News
Sort by:
Top Post
AI Breakthrough for Faster, Cheaper and Injection-free Heart Scans
New artificial intelligence (AI) technology could lead to the next generation of heart MRI scans […]
Medtronic TYRX ™ Absorbable Antibacterial Envelope Is Effective at Reducing Infections in Cardiac Device Patients with Hematomas
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced new data from […]
Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the launch of the Prevail™ […]
Implicity Launches a Solution to Improve Remote Monitoring of Heart Failure Patients
Implicity, a leader in remote patient monitoring software and cardiac data management solutions, announced the […]
First Naturally-designed and Personalised Bioprosthesis SingValve Set to Revolutionise Heart Valve Surgery
A naturally-designed human-like personalised heart valve bioprosthesis named SingValve developed by a team of clinician-scientists […]
SCAS CPR Resuscitation and Defibrillator App Save a Life Sees Spike in Downloads
An ambulance service app which provides cardiopulmonary resuscitation (CPR) guidance and locates the nearest defibrillator […]
Electroducer Announces Major Medical Advance in Treatment of Heart Valve Disease; Raises €3 Million to Market its Device in Europe and US – Commencing in 2022
Electroducer, the designer and developer of the innovative medical device Electroducer Sleeve®, which treats heart […]
Nuevocor Closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has announced the completion […]
NHS Kicks Off ‘CPR Army’ Following Footballer’s Collapse
England’s top doctor is sending out an army of volunteers to teach CPR after international […]
GENinCode Announces Major US Commercialisation Partnership with EVERSANA
GENinCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more